Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The coating is accompanied by a comprehensive suite of associated development and manufacturing services.
February 2, 2026
By: Patrick Lavery
Content Marketing Editor
Freudenberg Medical has launched LUBRITEQ, a new, high-performance hydrophilic coating solution. Alongside this, the company released a comprehensive suite of associated development and manufacturing services.
To define LUBRITEQ further, Freudenberg said it is an advanced, ultraviolet (UV)-curable, single-step hydrophilic coating. It will have a wide range of medical device applications and is customizable for optimized performance. The comprehensive services model supports customers through the full product lifecycle, eliminating handoffs between multiple suppliers.
Freudenberg Medical, a global CDMO partner to the biopharma and medical device industries, said LUBRITEQ is now available worldwide.
Consequently, Freudenberg said it is the only hydrophilic coating provider pairing advanced surface chemistry with in-house design and manufacturing capabilities. Together, according to the company, these complementary technologies not only enhance manufacturability but also boast greater productivity and reliability.
However, before entering the hydrophilic coatings market, Freudenberg consulted with customers and industry stakeholders to identify unmet needs. And while technologies have advanced, the company found that the needs of customers were still not being fulfilled.
“We heard consistent feedback that directly shaped our strategy,” said Keith Kiernan, Freudenberg Medical Chief Commercial Officer. “Customers aren’t just looking for a better coating—they’re looking for a better partner to de-risk their product launches.”
Kiernan said the company deliberately attempted to create a solution and partnership model reflecting those concerns. “No royalties, no rigidity—just coating performance, partnership and progress,” he said.
News of the new coating followed Freudenberg Medical’s ribbon-cutting of a new production facility in Costa Rica. That became official, realizing a $25 million investment, in late September 2025.
At the time, plans were to double the site’s area—from 50,000 to 100,000 square feet—in three years.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !